Calendar MaaT Pharma

Equities

MAAT

FR0012634822

Market Closed - Euronext Paris 08:05:14 2024-04-26 am EDT 5-day change 1st Jan Change
9.06 EUR 0.00% Intraday chart for MaaT Pharma +3.90% +29.80%

Chart calendar MaaT Pharma

6c2eb3eaabc1ede6f4e686c244347.vBPMEZnUwVsXQr4qOLFQQNMppHgnYw_rlu8d9eTNrr4.112_U--8kx9TDs0eDeAKdP5E4xMfTkSPxadTsoa058jOKrt-qqL1E34T9w~e3b2a6fe7d8e2e17b7809ac0ca1b5a54

Upcoming events on MaaT Pharma

2024-05-13 Q1 2024 Sales and Revenue Release
2024-05-28 05:00 am Annual General Meeting
2024-06-10 Portzamparc Mid & Small Caps Conference
2024-06-24 Stifel European Healthcare Summit
2024-09-18 Q2 2024 Earnings Release
2024-11-04 Q3 2024 Sales and Revenue Release
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-09-23 Q2 2025 Earnings Release (Projected)
2026-03-25 Q4 2025 Earnings Release (Projected)
2026-09-29 Q2 2026 Earnings Release (Projected)

Past events on MaaT Pharma

2024-04-16 European Society for Blood and Marrow Transplantation Meeting
2024-04-14 Van Lanschot Kempen Life Sciences Conference
2024-04-13 European Bone Marrow Transplant Meeting
2024-04-10 12:00 pm American Association for Cancer Research Meeting - Abstract Number: 6687
2024-03-28 01:00 pm Q4 2023 Earnings Release
2024-01-07 Investor meeting
2023-12-18 12:00 pm Business Update Call
2023-12-11 06:00 pm American Society of Hematology Meeting - Poster number: 4947
2023-12-10 06:00 pm American Society of Hematology Meeting - Poster number: 3553
2023-11-14 Francophone Society of Marrow Transplantation and Cellular Therapy Congress
2023-11-13 Investor meeting
2023-11-09 12:30 pm Q3 2023 Sales and Revenue Release
2023-10-31 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1321
2023-10-31 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1304
2023-10-08 Investor Access Event
2023-10-03 KBC Securities Life Sciences Conference
2023-10-03 Portzamparc Biotech & Health Seminar
2023-09-26 LPB Regional Values Forum
2023-09-26 12:00 pm Q2 2023 Earnings Release
2023-07-27 12:00 pm Q2 2023 Sales and Revenue Release

Annual results

Fiscal PeriodDecember 2020 2021 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
2,14


0,97
1,20
-19%
2,23
5,00
-55.44%

4,00

EBITDA
Million EUR
Released
Forecast
Spread
0,00


-8,57
-16,1
46.8%
-19,1
-22,8
16.35%

-29,0

EBIT
Million EUR
Released
Forecast
Spread
0,00


0,00
0,00
-
-19,9
-23,1
13.67%

-29,5

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,00


0,00
0,00
-
-19,7
-23,3
15.38%

-29,0

Net income
Million EUR
Released
Forecast
Spread
0,00


0,00
0,00
-
-19,7
-23,3
15.38%

-29,6

EPS
EUR
Released
Forecast
Spread
-25,7


0,00
0,00
-
-1,70
-2,37
28.27%

-2,55

Announcement Date04/10/2114/04/2228/03/24-

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise